UPDATE: Auspex Pharma Expecting Top-Line Data from Phase 2/3 Trial for SD-809 During Mid 2015

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.